शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Tue, 13 Jan, 2026 · 16:22 IST

Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹5865.00
prior close
₹5888.00
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.2%-0.9% vs market
Pharmaceuticals peers, median of 154sector+0.1%-0.9% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Midcap 150 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.9
10m
-0.7
15m
-0.6
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7+0.2-0.9+0.1-0.9
Next day
-0.4+0.3-0.7-0.4-0.0
2d
-2.4-0.2-2.2-1.5-0.9
3d
-3.3-2.7-0.6-3.8+0.5
4d
-4.0-3.7-0.4-4.7+0.7
5d
-2.1-2.5+0.4-3.8+1.7
1w
-1.9-3.6+1.8-5.2+3.3
15d
-4.7+0.0-4.8-2.9-1.8
1m
-6.6+0.3-6.9-2.1-4.5
2m
-9.8-8.0-1.8-9.4-0.4
3m
-4.7-1.3-3.5-2.8-1.9
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has received an order from the Commissioner of GST & Central Excise (Appeals-II), Chennai, related to its Tamil Nadu GSTIN for the period 2017-18 to 2019-20. The order demands GST of about Rs. 3.83 crore along with interest and a penalty of Rs. 38.34 lakh, alleging short payment of taxes. The company has stated that it disagrees with the order, maintains that taxes were correctly paid, and intends to file an appeal. Alkem has clarified that there is no material impact on its financial, operational, or other activities from this order.

Likely market impact

The demand amount (~Rs. 4.21 crore excluding interest) is small relative to Alkem's overall scale, and since the company is contesting it, the immediate hit to shareholders is limited. Investors should track the appeal outcome, as a final adverse ruling could add to tax outflow.